| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8246714 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusion: Hyperfractionated accelerated RT was the main tool in obtaining responses in S-PNET; introducing the myeloablative phase improved the prognosis (3/10 vs. 3/5 relapses), though the outcome remained unsatisfactory despite the adoption of this intensive treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Maura M.D., Lorenza M.D., Filippo M.D., Roberto M.D., Paola M.D., Felice M.D., Fabio M.D., Michela M.D., Graziella M.D., Emanuele M.D., Andrea M.D., Monica M.D., Marta M.D., Cristina M.D., Daniela M.D., Geraldina M.D., Fernando M.D., Franca M.D.,